1921 - 1930 of 9016 Results
Title
Year
- The ice test to differentiate essential tremor from Parkinson’s disease tremor2017RESTRICTEDTitle: The ice test to differentiate essential tremor from Parkinson’s disease tremorJournal Name: Clinical NeurophysiologyPublisher: Elsevier BVVol: 128Issue #: 11Start Page: 2181End Page: 2183Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.clinph.2017.08.015Citation Count: 5
-
OPENTitle: K2S2O8-mediated coupling of 6-amino-7-aminomethyl-thiazolino-pyridones with aldehydes to construct amyloid affecting pyrimidine-fused thiazolino-2-pyridonesJournal Name: Organic & Biomolecular ChemistryPublisher: Royal Society of Chemistry (RSC)Vol: 19Issue #: 44Start Page: 9758End Page: 9772Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1039/d1ob01580jBest OA location URL: https://pubs.rsc.org/en/content/articlepdf/2021/ob/d1ob01580jCitation Count: 1
-
OPENTitle: Biological Staging of the Parkinson’s Progression Markers Initiative (PPMI) Cohort Using the Research Neuronal α-synuclein Disease Integrated Staging System (NSD-ISS) (P11-3.009)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 102Issue #: 7_supplement_1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000204771Best OA location URL: https://resolver.sub.uni-goettingen.de/purl?gro-2/154631Citation Count: 0
-
OPENTitle: Auto-annotating sleep stages based on polysomnographic dataJournal Name: PatternsPublisher: Elsevier BVVol: 3Issue #: 1Start Page: 100371End Page: 100371Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.patter.2021.100371Best OA location URL: https://doi.org/10.1016/j.patter.2021.100371Citation Count: 31
- No PD Dyskinesia Scale Protects Against Placebo Responses: A Comparison of Multiple Scales (P04.187)2013RESTRICTEDTitle: No PD Dyskinesia Scale Protects Against Placebo Responses: A Comparison of Multiple Scales (P04.187)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 80Issue #: 7_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.80.7_supplement.p04.187Citation Count: 0
-
OPENTitle: Subtype definition of vascular parkinsonismJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 52Issue #:Start Page: 107End Page: 108Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.03.005Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6019183Citation Count: 2
-
OPENTitle: Neurogenesis in Cancun: where science meets the seaJournal Name: DevelopmentPublisher: The Company of BiologistsVol: 143Issue #: 10Start Page: 1649End Page: 1654Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1242/dev.138412Best OA location URL: https://journals.biologists.com/dev/article-pdf/143/10/1649/1842172/dev138412.pdfCitation Count: 0
-
OPENTitle: Impact of L-DOPA treatment on regional cerebral blood flow and metabolism in the basal ganglia in a rat model of Parkinson's diseaseJournal Name: NeuroImagePublisher: Elsevier BVVol: 61Issue #: 1Start Page: 228End Page: 239Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuroimage.2012.02.066Best OA location URL: http://doi.org/10.1016/j.neuroimage.2012.02.066Citation Count: 77
-
OPENTitle: Novel method to ascertain chromatin accessibility at specific genomic loci from frozen brain homogenates and laser capture microdissected defined cellsJournal Name: NeuroepigeneticsPublisher: Elsevier BVVol: 6Issue #:Start Page: 1End Page: 9Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nepig.2016.03.001Best OA location URL: https://doi.org/10.1016/j.nepig.2016.03.001Citation Count: 0
-
OPENTitle: Phosphoproteomic evaluation of pharmacological inhibition of leucine‐rich repeat kinase 2 reveals significant off‐target effects of LRRK‐2‐IN‐1Journal Name: Journal of NeurochemistryPublisher: WileyVol: 128Issue #: 4Start Page: 561End Page: 576Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/jnc.12483Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.12483Citation Count: 66